Literature DB >> 32573358

Neurochemical metabolite alterations of the occipital lobe in migraine without aura by proton magnetic resonance spectroscopy.

Alireza Dehghan1, Erfan Saatchian1, Mohammadreza Sobhani2, Alireza Montazerabadi1.   

Abstract

BACKGROUND: Migraine without aura is the most common type of migraine headache, accounting for about 80% of all migraines. The aim of the present investigation was to determine the neurochemical metabolite alterations in the occipital lobe of patients suffering from migraine without aura using proton magnetic resonance spectroscopy (1H-MRS).
METHODS: Fifteen patients suffering from migraine without aura with an occipital plaque and 16 healthy controls were included in this study. Changes in the neurochemical metabolites in the occipital lobe were assessed using 1H-MRS. The ratios of N-acetylaspartate (NAA) to creatine (Cr), choline (Cho) to Cr and myo-inositol (MI) to NAA were measured by voxel volume at 8 cm3.
RESULTS: The mean NAA/Cr ratio decreased significantly in patients compared to controls. Cho/Cr and MI/NAA ratios increased significantly in patients. In addition, the duration of the disease and the frequency of headache attacks were significantly associated with a decrease in the NAA/Cr ratio and an increase in the Cho/Cr ratio.
CONCLUSIONS: Migraine without aura shows a significant association with changes in neurochemical metabolites detectable by 1H-MRS in the occipital lobe of patients. In addition, changes in metabolic ratios showed a significant relationship with the duration of the disease and the frequency of headache attacks.

Entities:  

Keywords:  Migraine without aura; neurochemical metabolite; proton magnetic resonance spectroscopy

Mesh:

Substances:

Year:  2020        PMID: 32573358      PMCID: PMC7482038          DOI: 10.1177/1971400920932793

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  35 in total

1.  Cerebrospinal fluid analyses in migraine patients and controls.

Authors:  J F Rothrock; K R Mar; T L Yaksh; A Golbeck; A C Moore
Journal:  Cephalalgia       Date:  1995-12       Impact factor: 6.292

2.  Effect of N-acetylaspartic acid on the diffusion coefficient of water: a proton magnetic resonance phantom method for measurement of osmolyte-obligated water.

Authors:  Morris H Baslow; David N Guilfoyle
Journal:  Anal Biochem       Date:  2002-12-15       Impact factor: 3.365

Review 3.  The epidemiology of primary headache disorders.

Authors:  Matthew S Robbins; Richard B Lipton
Journal:  Semin Neurol       Date:  2010-03-29       Impact factor: 3.420

4.  Higher glutamate to glutamine ratios in occipital regions in women with migraine during the interictal state.

Authors:  Jesús González de la Aleja; Ana Ramos; Virginia Mato-Abad; Antonio Martínez-Salio; Juan A Hernández-Tamames; José Antonio Molina; Jesús Hernández-Gallego; Juan Alvarez-Linera
Journal:  Headache       Date:  2012-12-20       Impact factor: 5.887

5.  Functional 1H-MRS findings in migraine patients with and without aura assessed interictally.

Authors:  Paola Sarchielli; Roberto Tarducci; Otello Presciutti; Gianni Gobbi; Gian Piero Pelliccioli; Giuseppe Stipa; Andrea Alberti; Giuseppe Capocchi
Journal:  Neuroimage       Date:  2005-01-05       Impact factor: 6.556

Review 6.  Advanced neuroimaging of migraine.

Authors:  Todd J Schwedt; David W Dodick
Journal:  Lancet Neurol       Date:  2009-06       Impact factor: 44.182

7.  Cerebellar metabolite alterations detected in vivo by proton MR spectroscopy.

Authors:  M A Macrì; G Garreffa; F Giove; A Ambrosini; M Guardati; F Pierelli; J Schoenen; C Colonnese; B Maraviglia
Journal:  Magn Reson Imaging       Date:  2003-12       Impact factor: 2.546

8.  Brain pH in migraine: an in vivo phosphorus-31 magnetic resonance spectroscopy study.

Authors:  K M Welch; S R Levine; G D'Andrea; J A Helpern
Journal:  Cephalalgia       Date:  1988-12       Impact factor: 6.292

Review 9.  The Chronic Migraine Brain: What Have We Learned From Neuroimaging?

Authors:  Massimo Filippi; Roberta Messina
Journal:  Front Neurol       Date:  2020-01-09       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.